A team of researchers at Kyushu University in Japan in the latest issue of the US “Clinical examination magazine” reported that they found in animal studies for the treatment of chronic hepatitis B, to curb cancer metastasis.
British medical journal “The Lancet” the report said, the early clinical results of experimenting with an Ebola vaccine in Africa’s “encouraging”, and confirmed the safety of the vaccine is capable of eliciting an immune response. However, its effects and the duration of immunity remains to be verified.
Japanese researchers have developed an antibody to reduce the lead to Alzheimer’s disease (Alzheimer’s disease) abnormal Tau protein in the brain, and successfully improved the memory of mice. This will help develop the treatment of Alzheimer’s disease drugs.
In the United States, almost no one can be traced back to their ancestors come from only one place. According to a new study, for many people, their past might be surprising.
The research team published in the scientific journal Nature reported that through experiments with rats, the drug is expected to open a new page in bacterial diseases war, but licensed for human use may have to wait another 5-6 years.
the core issue is the vertebrate immunology research how to adjust their defense in response to bacteria and viruses, the latter two chemicals showed almost unlimited diversity. Good laboratory in adding two years, Cooper made a discovery on lymphocytes, which are proven to crack the mystery and eventually unify these two camps in the area of research played a crucial role.
Institute of Standards and Science Korea (RISSK) completed the Korean blood brain imaginary map, they accounted for 80% of cerebral stroke degree according to age into a 1-100 rating.
Copyright © 2024 | ANT MEDIC